TB-BIOCHIP-2
(Registration certificate N ФС 01012006/3257-06)
"TB-Biochip-2" test-system allows detecting not less that 80% of fluoroquinolone-resistant strains of TB causative agent during less than 1 day. This test-system is applied for the determination of exact type of mutation which leads to the resistance against fluoroquinolones.
Advantages of the test-system |
Similar to "TB-BIOCHIP" test-system |
Assay procedure |
Sensitivity and specificity |
Reports in the specialized ImageWare computer program
Comments for non-specialists:
- Tuberculosis is detected.
- Resistance against fluoroquinolones is revealed.
- Surgical treatment should be used or medical preparations for which sensitivity of TB bacteria has been retained should be applied.
Comments for non-specialists:
- Standard form of tuberculosis is detected.
- Treatment with fluoroquinolones is possible.
Composition of "TB-BIOCHIP-2" test-system
|
|
Photograph of the box containing "TB-BIOCHIP-2" biochips and hardware-software complex for the obtaining and analysis of fluorescence images from biochips
|
At the present time, the "TB-BIOCHIP-2" test-system is successfully used in the Central Scientific Research Institute of Tuberculosis (Moscow) and in Moscow Theoretical and Practical Center for Tuberculosis Control.
|
Fluoroquinolones - second-line anti-tuberculosis drugs that are used for the treatment of tuberculosis with multiple drug-resistance.
|